NCT06077435

Brief Summary

Purpose \& Research Questions The purpose of this study is to evaluate whether artificial intelligence (AI) improves the detection of polyps and whether the system can classify the type and severity of detected changes. The investigators will also assess if there are any differences between the various AI systems and whether the polyps that may be missed are benign or malignant.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
915

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started Mar 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Mar 2023Jun 2026

Study Start

First participant enrolled

March 1, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 27, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 11, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

November 24, 2025

Status Verified

November 1, 2025

Enrollment Period

3 years

First QC Date

September 27, 2023

Last Update Submit

November 19, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • To compare the effectiveness of AI systems in characterizing polyps with conventional histology

    The endoscopist's ability to characterize lesions with and without AI will be assessed, and this assessment will be compared to histology

    During procedure (5minutes)

  • Comparison of Adenoma Detection Rates (ADR) between colonoscopies assisted by Artificial Intelligence (AI) and conventional colonoscopies without AI

    The ADR is typically expressed as a percentage and is calculated using the following formula:Number of colonoscopies with adenoma detection/ Total number of colonoscopies ×100.

    During procedure (up to 40 minutes)

  • To assess and compare the costs associated with AI-assisted colonoscopy versus conventional colonoscopy.

    Each cost associated with each examination, whether using AI-assisted or conventional colonoscopy, will be recorded prospectively.

    During procedure (5minutes)

Study Arms (4)

CAD-EYE

ACTIVE COMPARATOR

AI system 1. Sealed envelopes in blocks of four were used for randomisation.

Device: AI

GI-GENIUS

ACTIVE COMPARATOR

AI system 2. Sealed envelopes in blocks of four were used for randomisation

Device: AI

Endo-AID

ACTIVE COMPARATOR

AI system 3. Sealed envelopes in blocks of four were used for randomisation

Device: AI

No AI

NO INTERVENTION

No AI. conventional examination. Sealed envelopes in blocks of four were used for randomisation

Interventions

AIDEVICE

AI system

CAD-EYEEndo-AIDGI-GENIUS

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 50 years
  • Elective colonoscopy

You may not qualify if:

  • Patient declines to participate in the study.
  • Age \< 50 years
  • Unprepared bowel

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sahlgrenska University Hospital

Gothenburg, Gothenbburg, 41345, Sweden

RECRUITING

MeSH Terms

Conditions

Colonic Polyps

Condition Hierarchy (Ancestors)

Intestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Per Hedenstrom, MD. Ph D

    Sahlgrenska University Hospital

    STUDY DIRECTOR

Central Study Contacts

Jonas Varkey, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: A Randomized Controlled Trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, Senior Consultant, MD, PhD,

Study Record Dates

First Submitted

September 27, 2023

First Posted

October 11, 2023

Study Start

March 1, 2023

Primary Completion

March 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

November 24, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations